//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 09 August, 2020, 08:07 AM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    Abbott India Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 07 Aug, 2020, 03:57 PM IST
    16199.00

    Today's Change

    44.50 (0.28%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    15,324

    Open

    16248.55

    Prev. Close

    16154.50

    Day's Trend

    Low
    16079.05
    High
    16298.70
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)10.00
    • EPS-TTM (Rs.)279.04
    • BV/share (₹)1144.33
    • 52Wk L/H8521.00/ 18679.75
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News
    Abbott India Ltd.Unaudited Financial Results Of The Company For The First Quarter Ended On June 30, 2020| Announcement
    Abbott India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Abbott India Ltd.Board Meeting Intimation for Approving The Text Of Unaudited Financial Results Of The Company For The First Quarter End...| Announcement
    Abbott India Ltd.Shareholding for the Period Ended June 30, 2020| Announcement
    Abbott India Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
    Abbott India Ltd.Statement Of Investor Complaints For The Quarter Ended June 2020| Announcement
    Abbott India Ltd.Disclosure Of Related Party Transactions For The Year Ended March 31, 2020| Announcement
    Abbott India Ltd.Closure of Trading Window| Announcement
    Abbott India Ltd.Announcement under Regulation 30 (LODR)-Change in Directorate| Announcement
    Abbott India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Abbott India Ltd.Compliances-Reg.24(A)-Annual Secretarial Compliance| Announcement
    Abbott India Ltd.Book Closure For The Purpose Of Annual General Meeting And Payment Of Dividend.| Announcement
    Abbott India Ltd.Audited Financial Results Of The Company For The Quarter And Year Ended On March 31, 2020| Announcement
    Abbott India Ltd.Audited Financial Results Of The Company For The Quarter And Year Ended On March 31, 2020| Announcement
    Abbott India Ltd.Corporate Action-Board approves Dividend| Announcement
    Abbott India Ltd.Announcement under Regulation 30 (LODR)-Change in Directorate| Announcement
    Abbott India Ltd.Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
    Abbott India Ltd.Result Of Postal Ballot (E-Voting) As Per Regulation 44 Of The Securities And Exchange Board Of India (Listing Obligatio...| Announcement
    Abbott India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Abbott India Ltd.Board Meeting Intimation for Approving The Text Of Audited Financial Results Of The Company For The Quarter And Year End...| Announcement
    Jawed Zia quits Abbott India| News
    Abbott India Q2 profit rises 30% to Rs 178 crore| News
    Abbott India Q1 profit up 42% to Rs 117 crore| News

    Abbott India Ltd. Share Price Updates

    Abbott India Ltd. share price up by 0.28% from its previous close of Rs 16154.50. Abbott India Ltd. stock last traded price is 16199.00
    Abbott India Ltd. Share Price
    Value
    Today/Current/Last
    16199.00
    Previous Day
    16154.50
    What's your view on Abbott India for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on Abbott India Ltd.

    Abbott India Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Mar 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    961.20
    -10.86
    6.06
    0.14
    961.20
    Other Operating Income
    0.00
    0.00
    0.00
    0.00
    0.00
    Operating Profit
    138.43
    -42.25
    -9.46
    -0.01
    624.68
    Other Income
    28.13
    1.33
    -4.19
    0.00
    45.22
    EBITDA
    166.56
    -37.73
    -8.61
    -0.01
    624.68
    Interest
    2.82
    51.61
    276.00
    0.00
    3.62
    Depreciation
    14.81
    -1.59
    201.63
    0.00
    28.41
    Tax
    37.96
    -40.56
    -40.14
    0.00
    49.20
    Net Profit
    110.97
    -40.56
    -1.96
    -0.97
    137.94
    EPS (₹)
    52.22
    -40.56
    -1.99
    -0.84
    52.22

    Abbott India Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    16199.00
    0.28
    4.27
    2.45
    -9.09
    88.95
    263.77
    236.88
    1488.70
    0.72
    3.58
    0.68
    2.56
    22.90
    24.07
    -18.87
    4383.50
    -0.15
    2.47
    6.55
    -5.21
    49.10
    143.75
    85.75
    8170.95
    -0.05
    5.19
    8.32
    3.13
    35.86
    87.89
    99.59
    3332.80
    -0.25
    -0.12
    -5.33
    5.19
    70.36
    264.54
    173.54
    4664.45
    5.73
    12.31
    9.88
    11.66
    1.17
    270.59
    430.23
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    Abbott India Ltd Risk Return Comparison

    with peersNew

    Abbott India Ltd
    Financial Comparison

    with peers
    Management Efficiency
    Abbott India Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    24.38
    10.38
    0.00
    24.38
    Return on Assets (%)
    16.72
    6.63
    -1.90
    16.72
    Return on capital Employed (%)
    26.82
    11.68
    -13.76
    26.82
    Fixed Assets Turnover (x)
    1.84
    1.40
    0.20
    2.50
    Profitability and Growth
    Gross Profit Margin (%)
    17.02
    11.30
    -5.25
    21.81
    Operating Profit Margin(%)
    18.48
    14.32
    3.25
    26.61
    Net Profit margin (%)
    14.48
    8.60
    -3.59
    23.66
    Financial Strength
    Liquidity
    Quick Ratio (x)
    2.45
    2.58
    0.14
    7.96
    Current Ratio (x)
    2.94
    3.09
    0.37
    8.87
    Cash ratio (x)
    1.97
    0.85
    0.01
    2.20
    Solvency
    Debt Equity Ratio (x)
    0.00
    0.46
    0.00
    3.21
    Coverage Ratios
    Cash flows to long term debt (x)
    0.00
    6.31
    0.00
    37.15
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    Abbott India Ltd Share Holding as on 30-06-2020

    CategoryNo. of sharesPercentage
    Promoters00.00
    ForeignInstitutions284,4751.34
    NBanksMutualFunds1,060,8864.99
    Others604,8242.85
    GeneralPublic3,154,95614.85
    FinancialInstitutions210,1130.99
    ForeignPromoter15,934,04874.99

    MF Ownership Of Abbott India Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    Equity: Large & MidCap
    53776
    25.24%
    1.51%
    83.55
    Axis Long Term Equity Direct-G
    Portfolio as on 31-07-2020
    Equity: ELSS
    28245
    -0.89%
    0.21%
    43.88
    Equity: Multi Cap
    21360
    0.00%
    1.48%
    33.19
    Axis ESG Equity Fund Direct-G
    Portfolio as on 31-07-2020
    Equity: Thematic
    13109
    0.00%
    1.18%
    20.37

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About Abbott India Ltd.

    Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 34421.74 Crore) operating in Pharmaceuticals sector.

    Abbott India Ltd. key Products/Revenue Segments include Injectables which contributed Rs 1507.14 Crore to Sales Value (40.97 % of Total Sales), Tablets which contributed Rs 1421.77 Crore to Sales Value (38.64 % of Total Sales), Liquids which contributed Rs 512.56 Crore to Sales Value (13.93 % of Total Sales), Capsules which contributed Rs 130.25 Crore to Sales Value (3.54 % of Total Sales), Others which contributed Rs 35.50 Crore to Sales Value (0.96 % of Total Sales), Service Income which contributed Rs 22.02 Crore to Sales Value (0.59 % of Total Sales), Ointments which contributed Rs 15.92 Crore to Sales Value (0.43 % of Total Sales), Other Operating Revenue which contributed Rs 15.37 Crore to Sales Value (0.41 % of Total Sales), Granules which contributed Rs 9.57 Crore to Sales Value (0.26 % of Total Sales), Powder which contributed Rs 7.58 Crore to Sales Value (0.20 % of Total Sales), Scrap which contributed Rs .69 Crore to Sales Value (0.01 % of Total Sales), Duty Drawback which contributed Rs .23 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2019.

    For the quarter ended 31-03-2020, the company has reported a Standalone sales of Rs 961.20 Crore, down -10.86 % from last quarter Sales of Rs 1078.25 Crore and up 6.06 % from last year same quarter Sales of Rs 906.31 Crore Company has reported net profit after tax of Rs 110.97 Crore in latest quarter.

    The company’s top management includes Mr.Ambati Venu, Mr.Kaiyomarz Marfatia, Mr.Mark Murphy II, Mr.Munir Shaikh, Mr.Rajiv Sonalker, Mr.Sudarshan Jain, Ms.Anisha Motwani, Ms.Shalini Kamath. Company has SRBC & Co LLP as its auditors As on 30-06-2020, the company has a total of 21,249,302 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors